<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01983800</url>
  </required_header>
  <id_info>
    <org_study_id>UHN 13-5845</org_study_id>
    <nct_id>NCT01983800</nct_id>
  </id_info>
  <brief_title>AnaConDa Long Term Sedation Study</brief_title>
  <acronym>VALTS</acronym>
  <official_title>Use of Volatile Anesthetics for Long-Term Sedation In Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heavy sedation or sleep is a common problem within the intensive care unit (ICU) using our
      standard intravenous medications. This commonly leads to confusion, low blood pressure, slow
      wake up and removal of the artificial breathing tube (extubation), which prolongs ICU stay.
      Using inhaled volatile anesthetic agents are likely to improve these patient outcomes. This
      unique project is the first North American study looking at using volatiles for patients who
      need longer-term ICU sedation. This project has excellent potential at lowering these
      complications and improving quality of care, which will lower patient ICU stay and healthcare
      costs.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Actual">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>atmospheric volatile concentration</measure>
    <time_frame>daily</time_frame>
    <description>Daily assessment of atmospheric volatile levels will be measured using photometric multigas infrared analyzer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sedation</measure>
    <time_frame>daily</time_frame>
    <description>adherence to the volatile sedation, sedation will be guided by explicit protocols targeting a Sedation-Agitation Score (SAS) of 3-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility</measure>
    <time_frame>2 years</time_frame>
    <description>assess rate of patient recruitment and barriers to recruitment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Education Tool</measure>
    <time_frame>2 years</time_frame>
    <description>multidisciplinary feedback regarding teaching package, protocol, quality of sedation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum fluoride levels</measure>
    <time_frame>every 2 days</time_frame>
    <description>Measurements will be taken 24 hours post sedation and every 2 days until while on sedation followed by 2 further samples after discontinuation of sedation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Intubated Requiring Sedation for Greater Than 48 Hours</condition>
  <arm_group>
    <arm_group_label>intravenous propofol/midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sedation using intravenous propofol/midazolam, sedation will be titrated to a Riker Agitation Sedation Score</description>
  </arm_group>
  <arm_group>
    <arm_group_label>isoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sedation using inhaled isoflurane, sedation will be titrated to a Riker Agitation Sedation Score</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane</intervention_name>
    <arm_group_label>isoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol/midazolam</intervention_name>
    <arm_group_label>intravenous propofol/midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult ICU patients expected to be ventilated &gt; 48 hours

        Exclusion Criteria:

          -  age &lt; 18 years

          -  history of malignant hyperthermia

          -  propofol infusion syndrome

          -  evidence of raised intracranial pressure

          -  6-month mortality risk from pre-existing condition &gt; 50%

          -  lack of commitment to maximal treatment

          -  pregnant

          -  NebulizedFlolan

          -  tidal volume &lt;350ml

          -  patients on one lung ventilation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela Jerath, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Toronto General Hospital, University Health Network</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital, University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2013</study_first_submitted>
  <study_first_submitted_qc>November 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2013</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mechanical Ventilation</keyword>
  <keyword>Volatile Sedation</keyword>
  <keyword>Intravenous Sedation</keyword>
  <keyword>Delirium</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

